328 related articles for article (PubMed ID: 27994093)
1. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
Geraldino-Pardilla L; Russo C; Sokolove J; Robinson WH; Zartoshti A; Van Eyk J; Fert-Bober J; Lima J; Giles JT; Bathon JM
Rheumatology (Oxford); 2017 Apr; 56(4):534-540. PubMed ID: 27994093
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
4. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
5. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
[TBL] [Abstract][Full Text] [Related]
6. Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.
Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Rönnelid J; Göransson U; Jakobsson PJ
Arthritis Res Ther; 2015 Jun; 17(1):155. PubMed ID: 26059223
[TBL] [Abstract][Full Text] [Related]
7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
8. Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis.
Geraldino-Pardilla L; Giles JT; Sokolove J; Zartoshti A; Robinson WH; Budoff M; Detrano R; Bokhari S; Bathon JM
Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1276-1281. PubMed ID: 27696777
[TBL] [Abstract][Full Text] [Related]
9. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
[TBL] [Abstract][Full Text] [Related]
10. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
[TBL] [Abstract][Full Text] [Related]
12. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
14. Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis.
Schwenzer A; Quirke AM; Marzeda AM; Wong A; Montgomery AB; Sayles HR; Eick S; Gawron K; Chomyszyn-Gajewska M; Łazarz-Bartyzel K; Davis S; Potempa J; Kessler BM; Fischer R; Venables PJ; Payne JB; Mikuls TR; Midwood KS
Arthritis Rheumatol; 2017 Dec; 69(12):2303-2313. PubMed ID: 29084415
[TBL] [Abstract][Full Text] [Related]
15. Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.
Quirke AM; Perry E; Cartwright A; Kelly C; De Soyza A; Eggleton P; Hutchinson D; Venables PJ
Arthritis Rheumatol; 2015 Sep; 67(9):2335-42. PubMed ID: 26017630
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity.
Trier NH; Dam CE; Olsen DT; Hansen PR; Houen G
PLoS One; 2015; 10(12):e0144707. PubMed ID: 26657009
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
19. Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis.
Norouzi S; Javinani A; Aminorroaya A; Masoumi M
BMC Cardiovasc Disord; 2020 Aug; 20(1):390. PubMed ID: 32847506
[TBL] [Abstract][Full Text] [Related]
20. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
Sokolove J; Brennan MJ; Sharpe O; Lahey LJ; Kao AH; Krishnan E; Edmundowicz D; Lepus CM; Wasko MC; Robinson WH
Arthritis Rheum; 2013 Jul; 65(7):1719-24. PubMed ID: 23553485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
